Hybrigenics SA

3HB-FF:Frankfurt Stock Exchange
RT Quote | Exchange | EUR
Last | 01/22/21 CET
0.211quote price arrow up+0.0138 (+7.00%)
52 week range
0.20 - 0.21

...

Loading . . .

KEY STATS

  • Open0.211
  • Day High0.211
  • Day Low0.211
  • Prev Close0.1972
  • 52 Week High0.21
  • 52 Week High Date01/22/21
  • 52 Week Low0.20
  • 52 Week Low Date01/13/21
  • Market Cap12.63M
  • Shares Out46.75M
  • 10 Day Average Volume3,153.33
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change156.07

RATIOS/PROFITABILITY

  • EPS (TTM)-0.26
  • P/E (TTM)-0.81
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Hybrigenics SA News

There is no recent news for this security.

Latest 3HB-FF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Hybrigenics SA is France-based Company engaged in the biotechnological sector. It specializes in the research and development of drugs intended for cancer treatment and supplies scientific services in the protein interaction field. The Company is specialized in the research and development (R&D) of drugs to fight cancer. It is organized in two units: Hybrigenics Pharma for internal R&D, which develops a research program aimed at such diseases as melanoma and prostate cancer;...
Alain Munoz Ph.D.
Chairman
Remi Delansorne
Chief Executive Officer
Guillaume Floch
Chief Financial Officer
Address
3-5 impasse Reille
Paris
75014
France